Sustained Minimal Residual Disease (MRD) Negativity for ≥1 Year in Transplant Eligible Newly Diagnosed Multiple Myeloma (NDMM): A Systematic Review of Prospective Clinical Trials

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Ali Awada, Amjad Alguraan, Ali Tarhini, Ali Tarhini, Yara Shatnawi, Haritha Gandicheruvu, Katia Kautaich, Faiz Anwer

DOI: 10.1016/j.jtct.2025.12.640

Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research Multiple Sclerosis Research Studies